These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3500233)

  • 1. Antibody conjugates with cobra venom factor. Synthesis and biochemical characterization.
    Petrella EC; Wilkie SD; Smith CA; Morgan AC; Vogel CW
    J Immunol Methods; 1987 Nov; 104(1-2):159-72. PubMed ID: 3500233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation.
    Zara J; Pomato N; McCabe RP; Bredehorst R; Vogel CW
    Bioconjug Chem; 1995; 6(4):367-72. PubMed ID: 7578355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate-directed conjugation of cobra venom factor to antibody by selective derivatization of the terminal galactose residues.
    Fu Q; Gowda DC
    Bioconjug Chem; 2001; 12(2):271-9. PubMed ID: 11312689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.
    Juhl H; Petrella EC; Cheung NK; Bredehorst R; Vogel CW
    Immunobiology; 1997 Nov; 197(5):444-59. PubMed ID: 9413745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach.
    Juhl H; Sievers M; Baltzer K; Helmig F; Wolf H; Brenner W; Kalthoff H
    Cancer Res; 1995 Dec; 55(23 Suppl):5749s-5755s. PubMed ID: 7493340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic.
    Juhl H; Petrella EC; Cheung NK; Bredehorst R; Vogel CW
    Mol Immunol; 1990 Oct; 27(10):957-64. PubMed ID: 2233757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
    Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
    Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
    Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
    Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cobra venom factor: structural homology with the third component of human complement.
    Vogel CW; Smith CA; Müller-Eberhard HJ
    J Immunol; 1984 Dec; 133(6):3235-41. PubMed ID: 6491285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of a neutralizing antibody response to humanized cobra venom factor in mice.
    Ing M; Hew BE; Fritzinger DC; Delignat S; Lacroix-Desmazes S; Vogel CW; Rayes J
    Mol Immunol; 2018 May; 97():1-7. PubMed ID: 29525557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
    Vogel CW; Fritzinger DC
    Curr Pharm Des; 2007; 13(28):2916-26. PubMed ID: 17979736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant cobra venom factor.
    Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
    Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective cytotoxicity of cobra venom factor immunoconjugate on cultured human nasopharyngeal carcinoma cell line.
    Wang XM; Huang SJ
    Hum Exp Toxicol; 1999 Feb; 18(2):71-6. PubMed ID: 10100018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity and function of oligosaccharides in cobra venom factor.
    Gowda DC; Petrella EC; Raj TT; Bredehorst R; Vogel CW
    J Immunol; 1994 Mar; 152(6):2977-86. PubMed ID: 8144897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and characterization of a complement-depleting factor from king cobra, Ophiophagus hannah.
    Zeng L; Sun QY; Jin Y; Zhang Y; Lee WH; Zhang Y
    Toxicon; 2012 Sep; 60(3):290-301. PubMed ID: 22561424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of native and recombinant cobra venom factor using thiophilic adsorption chromatography.
    Kölln J; Braren I; Bredehorst R; Spillner E
    Protein Pept Lett; 2007; 14(5):475-80. PubMed ID: 17584174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular isoforms of cobra venom factor-like proteins in the venom of Austrelaps superbus.
    Rehana S; Manjunatha Kini R
    Toxicon; 2007 Jul; 50(1):32-52. PubMed ID: 17412383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cobra venom factor: improved method for purification and biochemical characterization.
    Vogel CW; Müller-Eberhard HJ
    J Immunol Methods; 1984 Oct; 73(1):203-20. PubMed ID: 6491300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of immunoconjugates using antibody oligosaccharide moieties.
    Vogel CW
    Methods Mol Biol; 2004; 283():87-108. PubMed ID: 15197304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.
    Kölln J; Matzas M; Jänner N; Mix T; Klensang K; Bredehorst R; Spillner E
    Mol Immunol; 2004 May; 41(1):19-28. PubMed ID: 15140572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.